Isabelle Huys

Prof. dr. Isabelle Huys is pharmacist by training and with PhD in pharmaceutical sciences (toxicology) and further specialisation (LL.M. Munich) in regulations on medicinal product development at KU Leuven, including intellectual property rights.

Her research focusses on access to medicines and therapies. The research program studies diverse legal and regulatory aspects along the continuum of a medicinal product life cycle, from medicinal product discovery, development, approval, reimbursement and market adoption. The research program focuses on all types of medicinal products (small molecules, biologicals, advanced therapy medicinal products (ATMPs)) and diagnostics. Topics include biobanking and access to (human) biological samples and data, the use of real-world data/evidence (RWE) in medicinal product development and market access, repurposing of medicines for other (e.g. cancer) indications, patient preferences in medicinal product development and evaluation, precision medicine and companion diagnostics, off-patent strategies of biological products and market access of biosimilar and drug shortages. Isabelle Huys actively participated in several collaborative projects, bilateral university-industry, university-non-profit organisations, public-private partnerships of large scale (e.g. IMI, H2020, ERASMUS+, Marie-Curie ITN). Isabelle Huys supervises PhD projects in this research program and publishes the research in diverse journals.